JP2024533316A5 - - Google Patents
Info
- Publication number
- JP2024533316A5 JP2024533316A5 JP2024515072A JP2024515072A JP2024533316A5 JP 2024533316 A5 JP2024533316 A5 JP 2024533316A5 JP 2024515072 A JP2024515072 A JP 2024515072A JP 2024515072 A JP2024515072 A JP 2024515072A JP 2024533316 A5 JP2024533316 A5 JP 2024533316A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- domain
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241931P | 2021-09-08 | 2021-09-08 | |
| US63/241,931 | 2021-09-08 | ||
| PCT/US2022/076024 WO2023039407A2 (en) | 2021-09-08 | 2022-09-07 | Methods and compositions for modulating a genome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533316A JP2024533316A (ja) | 2024-09-12 |
| JP2024533316A5 true JP2024533316A5 (cg-RX-API-DMAC7.html) | 2025-09-17 |
Family
ID=85507691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515072A Pending JP2024533316A (ja) | 2021-09-08 | 2022-09-07 | ゲノムを調節するための方法及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240374759A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4399291A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024533316A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240099166A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118318037A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022344243A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3231676A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311219A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024002930A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023039407A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019327449B2 (en) | 2018-08-28 | 2026-04-09 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| IL296095A (en) | 2020-03-04 | 2022-11-01 | Flagship Pioneering Innovations Vi Llc | Improved methods and compositions for genome modulation |
| BR112022017715A2 (pt) | 2020-03-04 | 2022-11-16 | Flagship Pioneering Innovations Vi Llc | Métodos e composições para modular um genoma |
| CA3231712A1 (en) | 2021-09-08 | 2023-03-16 | Flagship Pioneering Innovations Vi, Llc | Pah-modulating compositions and methods |
| WO2025235506A2 (en) * | 2024-05-06 | 2025-11-13 | Flagship Pioneering Innovations Vi, Llc | Atp7b-modulating compositions and methods |
| CN118581153A (zh) * | 2024-08-05 | 2024-09-03 | 崖州湾国家实验室 | Dna聚合酶介导的核苷酸序列编辑方法及组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150044772A1 (en) * | 2013-08-09 | 2015-02-12 | Sage Labs, Inc. | Crispr/cas system-based novel fusion protein and its applications in genome editing |
| KR102415811B1 (ko) * | 2014-01-31 | 2022-07-04 | 팩터 바이오사이언스 인크. | 핵산 제조 및 송달을 위한 방법 및 산물 |
| CN110914310A (zh) * | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| WO2019051097A1 (en) * | 2017-09-08 | 2019-03-14 | The Regents Of The University Of California | RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME |
-
2022
- 2022-09-07 MX MX2024002930A patent/MX2024002930A/es unknown
- 2022-09-07 WO PCT/US2022/076024 patent/WO2023039407A2/en not_active Ceased
- 2022-09-07 KR KR1020247011697A patent/KR20240099166A/ko active Pending
- 2022-09-07 JP JP2024515072A patent/JP2024533316A/ja active Pending
- 2022-09-07 IL IL311219A patent/IL311219A/en unknown
- 2022-09-07 CN CN202280073061.3A patent/CN118318037A/zh active Pending
- 2022-09-07 AU AU2022344243A patent/AU2022344243A1/en not_active Abandoned
- 2022-09-07 US US18/690,134 patent/US20240374759A1/en active Pending
- 2022-09-07 EP EP22868262.1A patent/EP4399291A4/en active Pending
- 2022-09-07 CA CA3231676A patent/CA3231676A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024533311A5 (cg-RX-API-DMAC7.html) | ||
| JP2023506765A5 (cg-RX-API-DMAC7.html) | ||
| Brown et al. | Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ets-related proteins. | |
| Massung et al. | Potential virulence determinants in terminal regions of variola smallpox virus genome | |
| Schmalzbauer et al. | Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro | |
| JP2021522783A5 (cg-RX-API-DMAC7.html) | ||
| JP2025516294A5 (cg-RX-API-DMAC7.html) | ||
| JP2024533312A5 (cg-RX-API-DMAC7.html) | ||
| US20060182736A1 (en) | Transducible dna-binding proteins | |
| Smith et al. | The leucine zipper of c-Myc is required for full inhibition of erythroleukemia differentiation | |
| JP2017018125A5 (cg-RX-API-DMAC7.html) | ||
| US20150218227A1 (en) | Peptides for the binding of nucleotide targets | |
| US20230242627A1 (en) | Composition and method for activating latent human immunodeficiency virus (hiv) | |
| CN108778343A (zh) | 利用cpf1进行rna向导的基因编辑的方法和组合物 | |
| CN121343934A (zh) | 对补体灭活作用具有抗性的用于治疗癌症的包膜病毒 | |
| JP2018537089A5 (cg-RX-API-DMAC7.html) | ||
| JP2023504826A5 (cg-RX-API-DMAC7.html) | ||
| AU2005298245B2 (en) | A thymus-specific protein | |
| WO2013134249A1 (en) | Adipose tissue targeted peptides | |
| JP2024533314A5 (cg-RX-API-DMAC7.html) | ||
| CA3180251A1 (en) | Cytokine conjugates | |
| Hofacre et al. | Efficient therapeutic protein expression using retroviral replicating vector with 2A peptide in cancer models | |
| KR20220007619A (ko) | 면역조절 조성물 및 방법 | |
| JPH06502992A (ja) | 新しいヒト組み換えガンマ−インターフェロン | |
| CN107034201A (zh) | 表观修饰酶setd2的抗病毒作用及其应用 |